Delivery Order SPE2DB20D7061-SPE2DB24FSPN8
Award Date
8/23/24
Potential Completion Date
8/26/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3ml medication. The $14,832.32 firm fixed-price delivery order has an ultimate completion date of September 4, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $34,000.13 and is a Delivery Order with a Firm Fixed Price pricing type. The contract is for the delivery of the pharmaceutical product Ozempic, a 1 mg/dose (4 mg/3 ml) 3 ml injection. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a $2,269.38 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. This contract has an ultimate completion date of August 2, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various military treatment facilities, veterans' hospitals, and other federal healthcare...
This federal contract award to Amerisourcebergen Drug Corporation was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,516.60 firm fixed-price delivery order is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract has an ultimate completion date of September 20, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, Corporate Office Division, a major pharmaceutical distributor. The $58,615.99 firm fixed-price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,402.71 firm fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for diabetes management. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,161.08 firm fixed-price delivery order is for the supply of the medication Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The ceiling value of the Delivery Order is $1,334.46 and the ultimate completion date is August 14, 2024. The contract is a Firm Fixed Price arrangement and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The firm-fixed-price delivery order, valued at $7,355.61, has an ultimate completion date of August 28, 2024. This contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,110.21, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract is a firm fixed-price delivery order with a completion date of July 23, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...